drugset / Trial / NCT01436032

Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery

NCT01436032

Phase 3 Terminated 50 enrolled Alkermes, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.

Timeline

Start
2011-10
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Tromethamine Small molecule
Subject Meloxicam Small molecule 7.5 mg
Subject Meloxicam Small molecule 15 mg
Subject Meloxicam Small molecule 30 mg

Indications

No indication recorded.